GlassScriptPhysician profile
Donna M Civardi
NPI 1831230119
$6,112.18
in general payments reported to CMS, 2019-2025
30 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,019 · 2022: $984 · 2023: $876 · 2024: $1,823 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,938 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,938.34 |
| Education | $170.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,433.72 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Astellas Pharma US INC | $545.79 | 2022-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $463.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $443.94 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $413.92 | 2021-2025 | Trelegy Ellipta |
| Abbvie INC. | $400.11 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $394.01 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $205.89 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Exact Sciences Corporation | $194.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vanda Pharmaceuticals INC. | $169.73 | 2024-2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $168.95 | 2021-2024 | Trintellix |
| Eisai INC. | $133.91 | 2021-2022 | |
| Silk Road Medical, INC. | $132.39 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Axsome Therapeutics, INC. | $128.98 | 2023-2025 | Auvelity |
| Avanir Pharmaceuticals, INC. | $116.63 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.96 | 2022-2025 | Xifaxan, Trulance |
| Scilex Pharmaceuticals INC. | $85.03 | 2021-2025 | Ztlido |
| Phathom Pharmaceuticals, INC. | $75.89 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $67.89 | 2025 | Rexulti |
| Indivior INC. | $59.28 | 2025 | Sublocade |
| Vbi Vaccine (Delaware) INC. | $58.09 | 2022 | |
| Collegium Pharmaceutical, INC. | $56.86 | 2023 | Xtampza, Belbuca |
| Arbor Pharmaceuticals, INC. | $51.41 | 2021 | |
| Pfizer INC. | $46.66 | 2021-2024 | |
| Corium, LLC | $34.47 | 2024 | Azstarys |
| Kowa Pharmaceuticals America, INC. | $32.53 | 2021 | |
| Amarin Pharma, INC. | $32.48 | 2021 | |
| Bausch Health US, LLC | $20.57 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.64 | 2023 | Quviviq |
| Actelion Pharmaceuticals US, INC. | $15.81 | 2024 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Civardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.